Back
Esperion Therapeutics Stock Price Chart
Unlock the Secret to Earning Monthly Income!
Limited spots act swiftly
Sell
13
ESPR
Esperion Therapeutics
Last Price:
1.94
Seasonality Move:
0.71%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ESPR is experiencing slight selling pressure.
Esperion Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.16 | Sell |
| 20-day SMA: | 2.52 | Sell |
| 50-day SMA: | 2.47 | Sell |
| 200-day SMA: | 1.77 | Buy |
| 8-day EMA: | 2.14 | Sell |
| 20-day EMA: | 2.36 | Sell |
| 50-day EMA: | 2.39 | Sell |
| 200-day EMA: | 2.3 | Sell |
Esperion Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 33.87 | Sell |
| Chaikin Money Flow: | -2719701 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.01 - 2.87) | Sell |
| Bollinger Bands (100): | (1.82 - 2.78) | Sell |
Esperion Therapeutics Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Esperion Therapeutics Stock
Is Esperion Therapeutics Stock a Buy?
- Esperion Therapeutics share price is 1.87 while ESPR 8-day simple moving average is 2.16, which is a Sell signal.
- The stock price of ESPR is 1.87 while Esperion Therapeutics 20-day SMA is 2.52, which makes it a Sell.
- Esperion Therapeutics 50-day simple moving average is 2.47 while ESPR share price is 1.87, making it a Sell technically.
- ESPR stock price is 1.87 and Esperion Therapeutics 200-day simple moving average is 1.77, creating a Buy signal.
ESPR Technical Analysis vs Fundamental Analysis
Sell
13
Esperion Therapeutics (ESPR)
is a Sell
Is Esperion Therapeutics a Buy or a Sell?
-
Esperion Therapeutics stock is rated a Sell
The current Esperion Therapeutics [ESPR] share price is $1.87. The Score for ESPR is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Esperion Therapeutics Stock Info
Market Cap:
346.01M
Price in USD:
1.87
Share Volume:
5.96M
Esperion Therapeutics 52-Week Range
52-Week High:
3.40
52-Week Low:
0.70
Sell
13
Esperion Therapeutics (ESPR)
is a Sell
Esperion Therapeutics Share Price Forecast
-
What is the Esperion Therapeutics stock price today?
The Esperion Therapeutics stock price is 1.87 USD today. -
Will ESPR stock go up or go down?
Esperion Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Esperion Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Esperion Therapeutics is overvalued.
Is Esperion Therapeutics Stock a Buy?
- Esperion Therapeutics share price is 1.87 while ESPR 8-day exponential moving average is 2.14, which is a Sell signal.
- The stock price of ESPR is 1.87 while Esperion Therapeutics 20-day EMA is 2.36, which makes it a Sell.
- Esperion Therapeutics 50-day exponential moving average is 2.39 while ESPR share price is 1.87, making it a Sell technically.
- ESPR stock price is 1.87 and Esperion Therapeutics 200-day simple moving average is 2.30, creating a Sell signal.
Fundamental Analysis of Esperion Therapeutics
Is Esperion Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.10 per share, an increase this year of $1.59 per share, and an increase next year of $0.62 per share.
Technical Analysis of Esperion Therapeutics
Should I short Esperion Therapeutics stock?
- ESPR Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Esperion Therapeutics is a Sell
- Esperion Therapeutics Relative Strength Index (RSI) is 33.87, which suggest Esperion Therapeutics is oversold
- The Bollinger Bands (25) for Esperion Therapeutics is (2.01 - 2.87), which suggest Esperion Therapeutics is a Sell
- The Bollinger Bands (100) for Esperion Therapeutics is (1.82 - 2.78), which suggest Esperion Therapeutics is a Sell
* Esperion Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.